Terms of Use

Welcome to our website. We are pleased to provide you with information and links to information regarding our company.

Access and use of any information and/or materials from our website requires that you acknowledge certain of our intellectual property rights and to agree to certain terms in using the information and materials. We may change these terms without notice.

Limited License

All contents on our website are protected by copyright. You may view and copy materials on the public portions of our website solely for non-commercial, personal and informational use. Any copy of this material or information you copy shall retain all copyright and other proprietary notices in the same form and manner as on the original. No other use of the information is authorized.

Trademark Information

All trademarks, logos and service marks ("Marks") displayed on our website are the property of Exelixis or third parties. You are not permitted to use these Marks without our prior written consent or the prior written consent of the third party that owns the Mark.

Disclaimers

Although we have attempted to provide accurate information on our website, we assume no responsibility for the accuracy of the information. In particular, we may not update our website on a daily or other regular basis. As such, the information and materials contained on our website may be out of date or include omissions or other errors. We may change the information provided on our website at any time without notice.

All information provided on our website is provided "AS IS" without warranty of any kind. Exelixis, its affiliates and collaborators disclaim all warranties, express or implied, including those of merchantability and fitness for a particular purpose.

Limitation of Liability

Exelixis, its affiliates and collaborators shall not be liable for any direct, indirect, special, punitive, consequential or incidental damages resulting from use of our website or the materials, information or hyperlinks contained in it, or on any other hyperlinked website, even if Exelixis, its affiliates or partners have been expressly advised of the possibility of such damages. You agree to hold Exelixis, its affiliates and partners harmless from and against any claims or actions based upon or related to the use of our website or any hyperlinked website.

Forward-Looking Statements

This website contains forward-looking statements within the meaning of the federal securities laws, specifically the Securities Litigation Reform Act of 1995, including, without limitation, statements related to: the continued development and clinical, therapeutic and commercial potential of cabozantinib and of Exelixis’ other compounds and programs; Exelixis’ goal of being a commercial biopharmaceutical company that is making a positive difference in the lives of cancer patients; Exelixis’ goal of creating value for patients and its shareholders; the planned rolling submission of a new drug application for cabozantinib in medullary thyroid cancer (MTC) and the timing and response of the United States Food and Drug Administration (FDA) thereto; the planned initiation of the first pivotal trial for cabozantinib in prostate cancer and outcome of the company’s discussions with the FDA under a special protocol assessment with respect thereto; other planned pivotal trials of cabozantinib in prostate cancer and the timing with respect thereto; prospective business development activity and Exelixis’ projected future financial performance or events.  Words such as “believe,” “expect,” “intend,” “plan,” “look forward,” “anticipate,” “could,” “would,” “will,” “project,” “on track,” “going forward,” “potential,” “continue,” “goal,” “designed,” “demonstrate,” “outlook,” “forecast,” “position” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Exelixis' current plans, assumptions, beliefs and expectations. Forward-looking statements involve risks and uncertainties. Exelixis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation: risks related to the potential failure of cabozantinib to demonstrate safety and efficacy in clinical testing; Exelixis' ability to conduct clinical trials of cabozantinib sufficient to achieve a positive completion; the availability of data at the referenced times; the sufficiency of Exelixis' capital and other resources; the uncertain timing and level of expenses associated with the development of cabozantinib; the uncertainty of the FDA approval process; timely receipt of potential reimbursements, milestones, royalties and profits under Exelixis’ collaborative agreements; Exelixis’ ability to enter into new collaborations; market competition; and changes in economic and business conditions. These and other risk factors are discussed under "Risk Factors" and elsewhere in Exelixis' quarterly report on Form 10-Q for the quarter ended July 1, 2011 and Exelixis' other filings with the Securities and Exchange Commission. Exelixis expressly disclaims any duty, obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Exelixis' expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

Hyperlinks

Our website contains hyperlinks to websites owned and/or controlled by other parties. Access to any other website is at your own risk and we are not responsible for the accuracy or reliability of any information accessible from these websites. We provide these hyperlinks merely as a convenience and the hyperlinks are not an endorsement.

Governing Law and Jurisdiction

We reserve our right to any remedy available at law or equity in the event of your breach of these terms of use. All matters relating to your access to, or use of, our website shall be governed by U.S. federal law. Any legal action or proceeding relating to your access to, or use of, our website shall be instituted in a state court in San Mateo County, California or the U.S. district court for the Northern District of California. You agree to submit to the jurisdiction of, and agree that venue is proper in, these courts in any legal action or proceeding.